{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T18:33:31Z","timestamp":1776450811022,"version":"3.51.2"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13075-017-1299-8","type":"journal-article","created":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T01:36:43Z","timestamp":1494553003000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Comprehensive analysis of treatment response phenotypes in rheumatoid arthritis for pharmacogenetic studies"],"prefix":"10.1186","volume":"19","author":[{"given":"Kristopher A.","family":"Standish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Chris","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark E.","family":"Curran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"Schork","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,12]]},"reference":[{"issue":"10","key":"1299_CR1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.autrev.2011.04.021","volume":"10","author":"C Perricone","year":"1990","unstructured":"Perricone C, Ceccarelli F, Valesini G. An overview on the genetic of rheumatoid arthritis: a never-ending story. Autoimmun Rev. 1990; 10(10):599\u2013608. doi: 10.1016\/j.autrev.2011.04.021 .","journal-title":"Autoimmun Rev"},{"issue":"23","key":"1299_CR2","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. New Engl J Med. 2011; 365(23):2205\u201319. doi:10.1056\/NEJMra1004965.","journal-title":"New Engl J Med"},{"issue":"3","key":"1299_CR3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ng.1076","volume":"44","author":"S Raychaudhuri","year":"2012","unstructured":"Raychaudhuri S, Sandor C, Stahl EA, Freudenberg J, Lee HS, Jia X, et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet. 2012; 44(3):291\u20136. doi:10.1038\/ng.1076.","journal-title":"Nat Genet"},{"issue":"7488","key":"1299_CR4","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature12873","volume":"506","author":"Y Okada","year":"2014","unstructured":"Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature. 2014; 506(7488):376\u201381. doi:10.1038\/nature12873.","journal-title":"Nature"},{"issue":"3","key":"1299_CR5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrrheum.2012.237","volume":"9","author":"S Viatte","year":"2013","unstructured":"Viatte S, Plant D, Raychaudhuri S. Genetics and epigenetics of rheumatoid arthritis. Nat Rev Rheumatol. 2013; 9(3):141\u201353. doi:10.1038\/nrrheum.2012.237.","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"1299_CR6","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010; 62(9):2569\u201381. doi:10.1002\/art.27584.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1299_CR7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/annrheumdis-2013-203284","volume":"73","author":"H Radner","year":"2014","unstructured":"Radner H, Neogi T, Smolen JS, Aletaha D. Performance of the 2010 ACR\/EULAR classification criteria for rheumatoid arthritis: a systematic literature review. Ann Rheum Dis. 2014; 73(1):114\u201323. doi:10.1136\/annrheumdis-2013-203284.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"1299_CR8","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/ard.49.11.916","volume":"49","author":"DM van der Heijde","year":"1990","unstructured":"van der Heijde DM, van \u2019t Hof MA, van Riel PL, Theunisse LA, Lubberts EW, van Leeuwen MA, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis. 1990; 49(11):916\u201320.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1299_CR9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van \u2019t Hof MA, Kuper HH, van Leeuwenm MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995; 38(1):44\u20138.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"1299_CR10","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/ard.62.7.681","volume":"62","author":"T Skogh","year":"1995","unstructured":"Skogh T, Gustafsson D, Kjellberg M, Husberg M. Twenty eight joint count disease activity score in recent onset rheumatoid arthritis using C reactive protein instead of erythrocyte sedimentation rate. Ann Rheum Dis. 1995; 62(7):681\u20132. doi:10.1136\/ard.62.7.681.","journal-title":"Ann Rheum Dis"},{"key":"1299_CR11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/ard.62.7.624","volume":"62","author":"J Fransen","year":"2003","unstructured":"Fransen J, Welsing P, De Keijzer R, Van Riel P. Disease activity scores using C-reactive protein: CRP may replace ESR in the assessment of RA disease activity. Ann Rheum Dis. 2003; 62:151.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1299_CR12","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/art.1780380602","volume":"38","author":"DT Felson","year":"1995","unstructured":"Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. Preliminary definition of improvement in rheumatoid arthritis (American College of Rheumatology). Arthritis Rheum. 1995; 38(6):727\u201335.","journal-title":"Arthritis Rheum"},{"key":"1299_CR13","doi-asserted-by":"crossref","unstructured":"Felson DT, Smolen JS, Wells G, Zhang B, Van Tuyl LH, Funovits J, et al. American College of Rheumatology\/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis. 2005; 70(3):404\u201313. doi: 10.1136\/ard.2011.149765 .","DOI":"10.1136\/ard.2011.149765"},{"issue":"5 Suppl 39","key":"1299_CR14","first-page":"93","volume":"23","author":"J Fransen","year":"2005","unstructured":"Fransen J, van Riel PLCM. The disease activity score and the EULAR response criteria. Clin Exp Rheumatol. 2005; 23(5 Suppl 39):93\u20139.","journal-title":"Clin Exp Rheumatol"},{"key":"1299_CR15","doi-asserted-by":"crossref","unstructured":"Sen D, Paul JR, Ranganathan P. Pharmacogenetics in rheumatoid arthritis. In: Pharmacogenomics in Drug Discovery and Development: 2014. p. 625\u201360. https:\/\/rd.springer.com\/protocol\/10.1007%252F978-1-4939-0956-8_16 .","DOI":"10.1007\/978-1-4939-0956-8_16"},{"key":"1299_CR16","doi-asserted-by":"crossref","unstructured":"Zervou MI, Myrthianou E, Flouri I, Plant D, Chlouverakis G, Castro-Giner F, et al. Lack of association of variants previously associated with anti-TNF medication response in rheumatoid arthritis patients: results from a homogeneous Greek population. PLoS ONE. 2005; 8(9):74375. doi: 10.1371\/journal.pone.0074375 .","DOI":"10.1371\/journal.pone.0074375"},{"key":"1299_CR17","doi-asserted-by":"crossref","unstructured":"D\u00e1vila-Fajardo CL, van der Straaten T, Baak-Pablo R, Medarde Caballero C, Cabeza Barrera J, Huizinga TW, et al. FcGR genetic polymorphisms and the response to adalimumab in patients with rheumatoid arthritis. Pharmacogenomics. 2015; 16(4):373\u201381. doi: 10.2217\/pgs.14.178 .","DOI":"10.2217\/pgs.14.178"},{"key":"1299_CR18","doi-asserted-by":"crossref","unstructured":"Avila-Pedretti G, Tornero J, Fern\u00e1ndez-Nebro A, Blanco F, Gonz\u00e1lez-Alvaro I, Ca\u00f1ete JD, et al. Variation at FCGR2a and functionally related genes is associated with the response to anti-TNF therapy in rheumatoid arthritis. PLoS ONE. 2015; 10(4):0122088. doi: 10.1371\/journal.pone.0122088 .","DOI":"10.1371\/journal.pone.0122088"},{"key":"1299_CR19","doi-asserted-by":"crossref","unstructured":"Swierkot J, Bogunia-Kubik K, Nowak B, Bialowas K, Korman L, Gebura K, et al. Analysis of associations between polymorphisms within genes coding for tumour necrosis factor (TNF)-alpha and TNF receptors and responsiveness to TNF-alpha blockers in patients with rheumatoid arthritis. Joint Bone Spine. 2015; 82(2):94\u20139. doi: 10.1016\/j.jbspin.2014.08.006 .","DOI":"10.1016\/j.jbspin.2014.08.006"},{"key":"1299_CR20","doi-asserted-by":"crossref","unstructured":"Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet. 2011; 88(1):76\u201382. doi: 10.1016\/j.ajhg.2010.11.011 .","DOI":"10.1016\/j.ajhg.2010.11.011"},{"key":"1299_CR21","doi-asserted-by":"crossref","unstructured":"Plant D, Wilson AG, Barton A. Genetic and epigenetic predictors of responsiveness to treatment in RA. Nat Rev Rheum. 2014; 10(6):329\u201337. doi: 10.1038\/nrrheum.2014.16 .","DOI":"10.1038\/nrrheum.2014.16"},{"key":"1299_CR22","doi-asserted-by":"crossref","unstructured":"Umi\u0107evi\u0107 Mirkov M, Janss L, Vermeulen SH, van de Laar MAFJ, van Riel PLCM, Guchelaar HJ, et al. Estimation of heritability of different outcomes for genetic studies of TNFi response in patients with rheumatoid arthritis. Ann Rheum Dis. 2014; 74(12):2183\u20137. http:\/\/ard.bmj.com\/content\/74\/12\/2183.info .","DOI":"10.1136\/annrheumdis-2014-205541"},{"key":"1299_CR23","doi-asserted-by":"crossref","unstructured":"Weinblatt ME, Westhovens R, Mendelsohn AM, Kim L, Lo KH, Sheng S, et al. Radiographic benefit and maintenance of clinical benefit with intravenous golimumab therapy in patients with active rheumatoid arthritis despite methotrexate therapy: results up to 1 year of the phase 3, randomised, multicentre, double blind, placebo controlled GO-FURTHER trial. Ann Rheum Dis. 2014; 73(12):2152\u20139. doi: 10.1136\/annrheumdis-2013-203742 .","DOI":"10.1136\/annrheumdis-2013-203742"},{"issue":"3","key":"1299_CR24","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/annrheumdis-2012-201411","volume":"72","author":"ME Weinblatt","year":"2013","unstructured":"Weinblatt ME, Bingham CO, Mendelsohn AM, Kim L, Mack M, Lu J, et al. Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial. Ann Rheum Dis. 2013; 72(3):381\u20139. doi:10.1136\/annrheumdis-2012-201411.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1299_CR25","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12859-015-0736-4","volume":"16","author":"KA Standish","year":"2015","unstructured":"Standish KA, Carland TM, Lockwood GK, Pfeiffer W, Tatineni M, Huang CC, et al. Group-based variant calling leveraging next-generation supercomputing for large-scale whole-genome sequencing studies. BMC Bioinform. 2015; 16(1):304. doi:10.1186\/s12859-015-0736-4.","journal-title":"BMC Bioinform"},{"key":"1299_CR26","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2013","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2013. http:\/\/www.R-project.org\/ ."},{"issue":"6127","key":"1299_CR27","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1126\/science.1234139","volume":"339","author":"HL McLeod","year":"2013","unstructured":"McLeod HL. Cancer pharmacogenomics: early promise, but concerted effort needed. Science. 2013; 339(6127):1563\u20136. doi:10.1126\/science.1234139.","journal-title":"Science"},{"issue":"1","key":"1299_CR28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrg3352","volume":"14","author":"HE Wheeler","year":"2013","unstructured":"Wheeler HE, Maitland ML, Dolan ME, Cox NJ, Ratain MJ. Cancer pharmacogenomics: strategies and challenges. Nat Rev Genet. 2013; 14(1):23\u201334. doi:10.1038\/nrg3352.","journal-title":"Nat Rev Genet"},{"issue":"5 Suppl 39","key":"1299_CR29","first-page":"58","volume":"23","author":"T Sokka","year":"2005","unstructured":"Sokka T, Pincus T. Quantitative joint assessment in rheumatoid arthritis. Clin Exp Rheumatol. 2005; 23(5 Suppl 39):58\u201362.","journal-title":"Clin Exp Rheumatol"},{"key":"1299_CR30","doi-asserted-by":"crossref","unstructured":"Breivik H, Borchgrevink PC, Allen SM, Rosseland LA, Romundstad L, Hals EKB, et al. Assessment of pain. Br J Anaesth. 1991; 101(1):17\u201324. doi: 10.1093\/bja\/aen103 .","DOI":"10.1093\/bja\/aen103"},{"key":"1299_CR31","doi-asserted-by":"crossref","unstructured":"Villemure C, Bushnell MC. Mood influences supraspinal pain processing separately from attention. J Neurosci. 2009; 29(3):705\u201315. doi: 10.1523\/JNEUROSCI.3822-08.2009 .","DOI":"10.1523\/JNEUROSCI.3822-08.2009"},{"issue":"1","key":"1299_CR32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0005-7967(09)80006-5","volume":"29","author":"A Arntz","year":"1991","unstructured":"Arntz A, Dreessen L, Merckelbach H. Attention, not anxiety, influences pain. Behav Res Ther. 1991; 29(1):41\u201350.","journal-title":"Behav Res Ther"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-017-1299-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T14:12:08Z","timestamp":1569334328000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-017-1299-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,12]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1299"],"URL":"https:\/\/doi.org\/10.1186\/s13075-017-1299-8","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,12]]},"article-number":"90"}}